National Bank of Canada
LYRA

National Bank of Canada’s LYRA THERAPEUTICS INC LYRA Stock Holding History

National Bank of Canada’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-74
Closed -$951 – 3098
2024
Q3 		$951 Hold
74
– – ﹤0.01% 2432
2024
Q2 		$1.1K Hold
74
– – ﹤0.01% 2495
2024
Q1 		$1.39K Buy
+74
New +$19.7K ﹤0.01% 2504

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada's LYRA Position: Q4 2024 in Review

National Bank of Canada sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2024, closing a stake of 74 shares — an estimated $951 sold.

National Bank of Canada first reported a position in LYRA in Q1 2024 and held it in 3 quarters. The position peaked at $1.39K in Q1 2024. 54 funds tracked by Wall St. Rank hold LYRA as of Q4 2024.

  • National Bank of Canada reported no remaining LYRA THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • National Bank of Canada sold 74 LYRA THERAPEUTICS INC shares in Q4 2024, an estimated $951.
  • National Bank of Canada first reported a position in LYRA THERAPEUTICS INC in Q1 2024 and held it in 3 quarters.
  • National Bank of Canada's LYRA THERAPEUTICS INC position peaked at $1.39K in Q1 2024.
  • 54 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2024.

Based on National Bank of Canada's 13F filing for Q4 2024, filed 12 Feb 2025.